Jazz Pharmaceuticals Presents JZP-110 Data in Patients with Excessive Sleepiness Associated with Obstructive Sleep Apnea
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: PR Newswire
DUBLIN, June 6, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today presented positive efficacy results from its global multicenter studies (TONES 3 and TONES 4) of JZP-110 in adult patients with excessive sleepiness associated with obstructive sleep apnea (OSA). The data were presented in a poster session at the 31st Associated Professional Sleep Societies (APSS) Annual SLEEP Meeting in Boston."Obstructive sleep apnea (OSA) is a serious chronic sleep disorder in which breathing repeatedly stops and starts during sleep," said Karen Smith, M.D., Ph.D., executive vice president of research and development and chief medical officer of Jazz Pharmaceuticals. "These studies suggest that JZP-110 could provide an important treatment option for patients with excessive sleepiness with OSA who may not respond to, or may experience inadequate response to, their current wake-promoting therapies. It also underscores our commitment to making significant research and development inve
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024PR Newswire
- Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024PR Newswire
- Acute Lymphocytic Leukemia (ALL) Pipeline Landscape Report 2024: Comprehensive Insights About 250+ Companies and 250+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off [Seeking Alpha]Seeking Alpha
JAZZ
Earnings
- 2/28/24 - Beat
JAZZ
Sec Filings
- 4/9/24 - Form 4
- 3/8/24 - Form 4
- 3/7/24 - Form 4
- JAZZ's page on the SEC website